CHInese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy | Zendy

Narayanaswamy Venketasubramanian | Zendy; Sherry H. Young | Zendy; San San Tay | Zendy; Thirugnanam Umapathi | Zendy; Annabelle Y. Lao | Zendy; Herminigildo H. Gan | Zendy; Alejandro C. Baroque | Zendy; Jose C. Navarro | Zendy; Hui Meng Chang | Zendy; Joel Advincula | Zendy; Sombat Muengtaweepongsa | Zendy; Bernard P.L. Chan | Zendy; Carlos Chúa | Zendy; Nirmala Wijekoon | Zendy; H. Asita de Silva | Zendy; John Harold B. Hiyadan | Zendy; Nijasri C. Suwanwela | Zendy; Ka Sing Wong | Zendy; Niphon Poungvarin | Zendy; Gaik Bee Eow | Zendy; Chun Fan Lee | Zendy; Christopher Chen | Zendy

Open Access

CHInese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy

Author(s) -

Narayanaswamy Venketasubramanian,

Sherry H. Young,

San San Tay,

Thirugnanam Umapathi,

Annabelle Y. Lao,

Herminigildo H. Gan,

Alejandro C. Baroque,

Jose C. Navarro,

Hui Meng Chang,

Joel Advincula,

Sombat Muengtaweepongsa,

Bernard P.L. Chan,

Carlos Chúa,

Nirmala Wijekoon,

H. Asita de Silva,

John Harold B. Hiyadan,

Nijasri C. Suwanwela,

Ka Sing Wong,

Niphon Poungvarin,

Gaik Bee Eow,

Chun Fan Lee,

Christopher Chen

Publication year - 2015

Publication title -

cerebrovascular diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.221

H-Index - 104

eISSN - 1421-9786

pISSN - 1015-9770

DOI - 10.1159/000382082

Subject(s) - medicine , stroke (engine) , blinding , modified rankin scale , physical therapy , randomized controlled trial , placebo , stroke recovery , rehabilitation , surgery , ischemic stroke , mechanical engineering , alternative medicine , ischemia , pathology , engineering

The CHInese Medicine NeuroAiD Efficacy on Stroke recovery (CHIMES) study was an international randomized double-blind placebo-controlled trial of MLC601 (NeuroAiD) in subjects with cerebral infarction of intermediate severity within 72 h. CHIMES-E (Extension) aimed at evaluating the effects of the initial 3-month treatment with MLC601 on long-term outcome for up to 2 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research